Beximco gets DGDA approval to import Covid-19 vaccine from India

The Directorate General of Drug Administration (DGDA) has given approval Beximco Pharmaceuticals Ltd to import the Oxford-AstraZeneca Covid-19 vaccine from India.

The drug regulatory authority has just given a no objection certificate (NOC) to Beximco Pharma to import the vaccine from Serum Institute of India, said Ayub Hossain, spokesperson of DGDA.